Current Neuro-Oncology
Volume
26 Number 21
30 September 2024
Home > Publications > Current Neuro-Oncology > Volume 26, Year 2024 > Number 21, 30 September
Chan P, Nagai Y, Wu Q, Hovsepyan A, Mkhitaryan S, Wang J,
Karapetyan G, Kamenecka T, Solt LA, Cope J, Moats RA, Hirota T,
Rich JN, Kay SA.
Advancing Clinical
Response Against Glioblastoma: Evaluating SHP1705 CRY2 Activator
Efficacy in Preclinical Models and Safety in Phase I Trials.
bioRxiv [Preprint]. 2024 Sep 21:2024.09.17.613520.
doi:
10.1101/2024.09.17.613520. PMID:
39345648. Interventional study. ˍ
Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T,
Brannan C, Chalk T, Talacchi A, Mazzotta A, Narita Y, Sato H,
Miyakita Y, Shamieh O, Alrjoob W, Pace A, Petranovic D, Ploh M,
Capela A, Silva J, Hjermstad MJ, Purkart TU, Seidel C, Talhi N,
Pichler J, Höllmüller I, Brown L, Hand M, Klein M,
Aaronson NK, Uitdehaag BMJ, Taphoorn MJB, Dirven L; EORTC Quality
of Life Group and the EORTC Brain Tumor Group.
Instrumental
activities of daily living in neuro-oncology: International
validation of the EORTC IADL-BN32 questionnaire.
Eur
J Cancer. 2024 Sep 21;212:114335. doi:
10.1016/j.ejca.2024.114335. PMID:
39332215. Observational study. ˍ
Verducci C, Sloane DC, Hand R, Choe S, Jusue-Torres I, Shanker RM,
Kim M, Mallik AK, Germanwala AV, Anderson DE.
The
surgical management of third ventricle region tumors.
Clin
Neurol Neurosurg. 2024 Sep 21;246:108564. doi:
10.1016/j.clineuro.2024.108564. PMID:
39332050. Observational study˰
ˍ
Garelli G, Rovera G, Levis M, Lesca A, Pellerino A, Bruno F,
Agosti A, Mangia ML, Cioffi M, Coccarelli A, Morana G, Ricardi U,
Rudà R, Morbelli S, Zotta M.
[18F]DOPA
PET for lesion definition and contouring using different
thresholds in patients with gliomas.
Q
J Nucl Med Mol Imaging. 2024 Sep 23. doi:
10.23736/S1824-4785.24.03587-8. PMID:
39311479. Observational study˰
ˍ
Mergen E, Landrock S, Chizzali B.
Tumor
Treating Fields (TTFields) Therapy and Lomustine Chemotherapy for
the Treatment of Unresectable Progressive Glioblastoma.
Case
Rep Oncol. 2024 Sep 23;17(1):1056-1062. doi:
10.1159/000540669. PMID:
39474554. Case report. ˍ
Katzendobler S, Niedermeyer S, Blobner J, Trumm C, Harter PN, von
Baumgarten L, Stoecklein VM, Tonn JC, Weller M, Thon N, Weller J.
Determinants of long-term survival in
patients with IDH-mutant gliomas.
J
Neurooncol. 2024 Sep 24. doi:
10.1007/s11060-024-04826-9. PMID:
39316316. Observational study. ˍ
*Laviv Y, Regev O, Kanner AA, Fichman S, Limon D, Siegal T,
Yust-Katz S, Benouaich-Amiel A.
Stem
the blood flow: beneficial impact of bevacizumab on survival of
subventricular zone glioblastoma patients.
J
Neurooncol. 2024 Sep 24. doi:
10.1007/s11060-024-04828-7. PMID:
39316315. Observational study. ˍ
van Opijnen MP, de Vos FYF, Cuppen E, Geurts M, Maas SLN, Broekman
MLD.
The role of molecular biomarkers
in recurrent glioblastoma trials: an assessment of the current
trial landscape of genome-driven oncology.
Med
Oncol. 2024 Sep 24;41(11):250. doi:
10.1007/s12032-024-02501-7. PMID:
39316248. Observational study. ˍ
Brisson RJ, Indelicato DJ, Bradley JA, Aldana PR, Klawinski D,
Morris CG, Vega RBM.
Long-term
outcomes following proton therapy for pediatric spinal low-grade
glioma.
Pediatr
Blood Cancer. 2024 Sep 25:e31341. doi:
10.1002/pbc.31341. PMID:
39323035. Observational study˰
ˍ
Freire NH, Herlinger AL, Vanini J, Dalmolin M, Fernandes MAC, Nör
C, Ramaswamy V, de Farias CB, Brunetto AT, Brunetto AL, Gregianin
LJ, Jaeger MDC, Taylor MD, Roesler R.
Modulation
of Stemness and Differentiation Regulators by Valproic Acid in
Medulloblastoma.
bioRxiv
[Preprint]. 2024 Sep 25:2024.09.23.614476. doi:
10.1101/2024.09.23.614476. PMID:
39386542. Laboratory investigation. ˍ
Mughal AU, Khan MN.
High-grade
astrocytoma with piloid features: MRI findings associated with a
novel entity.
Radiol
Case Rep. 2024 Sep 25;19(12):6436-6439. doi:
10.1016/j.radcr.2024.09.097. PMID:
39380837. Case report. ˍ
Lim MS, Crimmins D.
The prognostic
utility of the neutrophil to lymphocyte ratio in paediatric brain
tumours: a retrospective case control study.
Br
J Neurosurg. 2024 Sep 26:1-7. doi:
10.1080/02688697.2024.2406804. PMID:
39324393. Observational study˰
ˍ
*Massimino M, Barretta F, Dossena C, Minasi S, Buttarelli FR,
Biassoni V, Oriani M, Schiavello E, Ficorilli M, Nigro O, Pollo B,
Antonelli M, Donofrio V, Maggioni M, Kool M, Pecori E, Vennarini
S, Giangaspero F, Gianno F, Erbetta A, Chiapparini L, Luksch R,
Barzanò E, Meazza C, Podda M, Spreafico F, Terenziani M,
Bergamaschi L, Ferrari A, Casanova M, Chiaravalli S, Gattuso G,
Modena P, Bailey S, De Cecco L.
Long-term
outcome of the Milano-HART strategy for high-risk medulloblastoma,
including the impact of molecular subtype.
Neuro
Oncol. 2024 Sep 27:noae189. doi:
10.1093/neuonc/noae189. PMID:
39331528. Observational study. ˍ
*Savoldi AP, Anghileri E, Moscatelli M, Silvani A, Pollo B,
Valeria C, Pascuzzo R, Aquino D, Grisoli M, Doniselli FM.
Fotemustine in recurrent high-grade
glioma: MRI neuro‑radiological findings.
Oncol
Lett. 2024 Sep 27;28(6):570. doi:
10.3892/ol.2024.14703. PMID:
39390978. Observational study. ˍ
Kebudi R, Yildirim UM, İribaş A, Tuncer S.
Optic
pathway gliomas in children: Clinical characteristics, treatment,
and outcome of 95 patients in a single center over a 31-year
period. Can we avoid radiotherapy?
Pediatr
Blood Cancer. 2024 Sep 29:e31337. doi:
10.1002/pbc.31337. PMID:
39344026. Observational study. ˍ
Carrillo J, Gill JM, Redfern C, Babic I, Nomura N, Shah DK,
Carrick S, Kesari S.
A phase 1 dose
escalation of pritumumab in patients with refractory or recurrent
gliomas or brain metastases.
Neurooncol
Adv. 2024 Sep 30;6(1):vdae166. doi:
10.1093/noajnl/vdae166. PMID:
39465217. Interventional study. ˍ
Leppert J, Ditz C, Grohmann M, Ziemann C, Hillbricht C, Liubich L,
Matone MV, Rades D, Gliemroth J, Löser A.
Therapy
Intensity Outweighs the Prognostic Importance of the Timing of
Chemoradiotherapy in Newly Diagnosed Glioblastoma Patients.
Anticancer
Res. 2024 Sep 30;44(10):4403-4412. doi:
10.21873/anticanres.17269. PMID:
39348995. Observational study. ˍ
Li X, Liu Z, Xu J.
Construction and
validation of a nomogram of risk factors and prognosis for elderly
patients with meningioma.
Asian
J Surg. 2024 Sep 30:S1015-9584(24)02036-0. doi:
10.1016/j.asjsur.2024.09.033. PMID:
39353766. Observational study. ˍ
Snider S, De Domenico P, Roncelli F, Bisoglio A, Braga M, Ghelfi
A, Barzaghi LR, Mura C, Mortini P, Gagliardi F.
Pre-operative
mean platelet volume is associated with overall survival in
patients with IDH-wildtype glioblastoma undergoing maximal safe
resection.
Oncol
Lett. 2024 Sep 30;28(6):576. doi:
10.3892/ol.2024.14709. PMID:
39397801. Observational study. ˍ
*Uke AD, Luharia A, Dahake S, Mishra GV, Mahakalkar C.
Exceptional Tumor Regression in
Diffuse Intrinsic Pontine Glioma Post-Radiotherapy: A Case
Study.
Am
J Case Rep. 2024 Sep 30;25:e944869. doi:
10.12659/AJCR.944869. PMID:
39348336. Case report. ˍ